Pharmacokinetics of nicotine in healthy elderly people

Clinical Pharmacology and Therapeutics

Volumn 69, Issue 1, 2001, Pages 57-65

  Molander, Lars ^a,b   Hansson, Anna ^a,b   Lunell, Erik ^a,b  

^a Pharmacia & Upjohn AB   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

ADULT; AGE; AGED; AGING; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG INDUCED DISEASE; DRUG URINE LEVEL; FEMALE; HEART PALPITATION; HEART RATE; HUMAN; KIDNEY CLEARANCE; LIFE EXPECTANCY; MALE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; STATISTICAL ANALYSIS; VERTIGO; XEROSTOMIA;

ADULT; AGED; AGING; BLOOD PRESSURE; COTININE; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NICOTINE; NICOTINIC AGONISTS;

EID: 0035139080     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.113181     Document Type: Article

References (42)

1. Smoking and mortality among older men and women in three communities
2. Tobacco smoking, ageing and health among the elderly: A longitudinal population study of 70-year old men and an age cohort comparison
3. Smoking and health in old age: A ten-year follow-up study
4. Mortality in relation to smoking: 40 years' observations on male British doctors
5. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications
6. Drug dosage in the elderly. Is it rational?
7. Pharmacokinetics and prescribing in the elderly
8. Clinical pharmacokinetic considerations in the elderly: An update
9. Prescribing for the elderly patient: Why do we need to exercise caution?
10. Pharmacokinetics in the elderly
11. Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years
12. Adult lean body mass declines with age: Some longitudinal observations
13. Body composition: Prediction of normal body potasssium, body water and body fat in adults on the basis of body height, body weight and age
14. Age differences in the water content of the body as related to basal oxygen consumption in males
15. The effect of age upon liver volume and apparent liver blood flow in healthy man
16. Hepatic drug clearance: The effect of age using indocyanine green as a model compound
17. The effect of age on creatinine clearance in men: A crosssectional and longitudinal study
18. Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged
19. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males
20. Altered pharmacodynamics in the elderly
21. Geriatric pharmacology: Basic and clinical considerations
22. Pharmacodynamics: Changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly
23. New methods for probing the disposition of nicotine in humans
24. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man
25. Individual differences in nicotine kinetics and metabolism in humans
26. Effect of urinary pH and nicotine excretion rate on plasma nicotine during cigarette smoking and chewing nicotine gum
27. Nicotine renal excretion rate influences nicotine intake during cigarette smoking
28. Pharmacokinetic considerations in understanding nicotine dependence
29. Chronopharmacokinetics of nicotine
30. Pharmacokinetics of nicotine after intranasal administration
31. Statistical estimations in pharmacokinetics
32. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site: Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I)
33. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site: Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II)
34. Cotinine disposition and effects
35. The benefits of stopping smoking and the role of nicotine replacement therapy in older patients
36. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking
37. Age as a factor in the metabolism of nicotine
38. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine
39. Age-related changes in β-adrenergic neuroeffector systems in the human heart
40. Reduced β-adrenoceptor sensitivity in the elderly
41. The effect of ageing on percutaneous absorption in man